Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
Survival Curves01:18

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changing standard of care during a randomized trial: examples, considerations and guidelines.

Journal of the National Cancer Institute·2026
Same author

Molecular Profiling for Precision Oncology: Moving Beyond Feasibility and Safety.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

A note on rank-preserving structural failure time models to account for crossover.

Clinical trials (London, England)·2026
Same author

Evaluating the impact of stratification on the power and cross-arm balance of randomized phase 2 clinical trials.

Clinical trials (London, England)·2025
Same author

Accrual Suspensions in Seamless Phase II/III Trials: A Review of NRG Oncology Trials.

JCO oncology advances·2025
Same author

Non-inferiority trials: tyranny or good governance?

The Lancet. Oncology·2025

Related Experiment Video

Updated: Jul 19, 2026

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

A testing procedure for survival data with few responders.

Boris Freidlin1, Edward L Korn

  • 1Biometric Research Branch, National Cancer Institute, 6130 Executive Blvd. EPN 8122, MSC-7434, Bethesda, MD 20892-7434, USA. friedlinb@ctep.nci.nih.gov

Statistics in Medicine
|January 10, 2002
PubMed
Summary

Selecting the right clinical trial analysis method is crucial when only some patients may benefit. This study offers guidelines for choosing tests based on expected responder fractions, optimizing trial power and accuracy.

More Related Videos

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Related Experiment Videos

Last Updated: Jul 19, 2026

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Area of Science:

  • Clinical Trial Design
  • Biostatistics
  • Survival Analysis

Background:

  • Clinical trials often involve treatments benefiting only a subset of patients.
  • Prospective specification of analysis procedures is essential for valid clinical trial design.
  • Identifying responders without prognostic factors necessitates sensitive testing procedures.

Purpose of the Study:

  • To propose guidelines for selecting appropriate statistical tests in clinical trials.
  • To ensure sensitivity to varying fractions of patient responders.
  • To optimize power in survival data analysis for clinical trials.

Main Methods:

  • Focus on survival data analysis.
  • Development of guidelines for test procedure selection based on anticipated responder proportions.
  • Comparison of logrank test with weighted linear rank tests.

Main Results:

  • Logrank test is recommended when the responder fraction exceeds 0.5.
  • Weighted linear rank tests are preferable for responder fractions below 0.5.
  • The proposed approach maintains good power for small responder fractions and protects against power loss when all patients respond.

Conclusions:

  • Guidelines enhance clinical trial design by optimizing statistical test selection.
  • The approach improves power and reliability in survival data analysis.
  • Recommendations are illustrated with data from two randomized studies.